Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- TWO2DFUIndependent statistical analysis of Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TWPSIndependent statistical analysis of Long-Term Effects of Torso-Weighting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743312).
- Tx for Child Sexual Behavior Problems: Complete Statistical AnalysisIndependent statistical analysis of Tx for Child Sexual Behavior Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02625571).
- TX-SMILEIndependent statistical analysis of Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03682965).
- Tx-TreatmentIndependent statistical analysis of Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TXAIndependent statistical analysis of TXA Study in Major Oncologic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01980355).
- TXAIndependent statistical analysis of Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TXA in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of TXA in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04272606).
- TXA Study in Major Burn Surgery: Complete Statistical AnalysisIndependent statistical analysis of TXA Study in Major Burn Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02753816).
- TXA vs. Amicar in Total Knee and Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of TXA vs. Amicar in Total Knee and Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030821).
- TXA-DosingIndependent statistical analysis of Tranexamic Acid Dosing for Major Joint Replacement Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05075200).
- TYRO Champion Dads Project Study: Complete Statistical AnalysisIndependent statistical analysis of TYRO Champion Dads Project Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256992).
- Tysabri JapanIndependent statistical analysis of Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TysexIndependent statistical analysis of The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- U-AccomplishIndependent statistical analysis of A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size…
- U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne: Complete Statistical AnalysisIndependent statistical analysis of U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne: primary endpoint results, effect estimate with confidence interval,…
- U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne: Complete Statistical AnalysisIndependent statistical analysis of U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne: primary endpoint results,…
- UAB0718Independent statistical analysis of UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval,…
- UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide: Complete Statistical AnalysisIndependent statistical analysis of UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission: Complete Statistical AnalysisIndependent statistical analysis of UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ubiquinol (Reduced COQ10) for Patients With Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Ubiquinol (Reduced COQ10) for Patients With Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01948063).
- Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: Complete Statistical AnalysisIndependent statistical analysis of Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276963).
- UBR ProdromeIndependent statistical analysis of Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- UCDCC#217Independent statistical analysis of Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- UDB P101Independent statistical analysis of Safety and Blood Level Study of Unit Dose Budesonide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00627679).
- UF CHALLENGEIndependent statistical analysis of A Net Ultrafiltration Challenge to Predict Preload-dependence (UF CHALLENGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05214729).
- UF-BMT-MRD-101Independent statistical analysis of Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease: primary endpoint results, effect estimate with confidence interval,…
- UGCAIndependent statistical analysis of Ustekinumab for the Treatment of Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955147).
- UGIH09067Independent statistical analysis of Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- UHSIndependent statistical analysis of Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632267).
- UKBCIndependent statistical analysis of The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ulcer Prevention Study in Post Gastric Bypass Patients: Complete Statistical AnalysisIndependent statistical analysis of Ulcer Prevention Study in Post Gastric Bypass Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00557349).
- ULIISIndependent statistical analysis of Ultrasound Liver Intraoperative Imaging With SonoVue®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01880554).
- ULT-218Independent statistical analysis of Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03320096).
- Ultherapy™ Treatment Following Sculptra® Treatment: Complete Statistical AnalysisIndependent statistical analysis of Ultherapy™ Treatment Following Sculptra® Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01422538).
- ULTRA-T2DIndependent statistical analysis of Uric Acid Lowering Trial in Youth Onset T2D: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03899883).
- Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ultrasound Device for Hair Removal: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Device for Hair Removal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01057134).
- Ultrasound Evaluation of Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Evaluation of Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03235180).
- Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ultrasound Guided Catheter Length Survivability: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Guided Catheter Length Survivability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03655106).
- Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03139435).
- Ultrasound Method to Measure Fibrosis of the Liver in Children: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Method to Measure Fibrosis of the Liver in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02086708).
- Ultrasound Prediction of Prolonged Labour: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Prediction of Prolonged Labour: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00915148).
- Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Ultrasound-guided Intermediate Cervical Plexus Block: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-guided Intermediate Cervical Plexus Block: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02794974).
- Ultrasound-Guided Landmark and Epidural Site Pain: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-Guided Landmark and Epidural Site Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02813681).
- Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04780919).